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Mutations in the polycystins cause autosomal dominant polycystic kidney disease (ADPKD).
Here we show that transmembrane protein 33 (TMEM33) interacts with the ion channel
polycystin-2 (PC2) at the endoplasmic reticulum (ER) membrane, enhancing its opening over
the whole physiological calcium range in ER liposomes fused to planar bilayers. Consequently,
TMEM33 reduces intracellular calcium content in a PC2-dependent manner, impairs lyso-
somal calcium reﬁlling, causes cathepsins translocation, inhibition of autophagic ﬂux upon ER
stress, as well as sensitization to apoptosis. Invalidation of TMEM33 in the mouse exerts a
potent protection against renal ER stress. By contrast, TMEM33 does not inﬂuence pkd2-
dependent renal cystogenesis in the zebraﬁsh. Together, our results identify a key role for
TMEM33 in the regulation of intracellular calcium homeostasis of renal proximal convoluted
tubule cells and establish a causal link between TMEM33 and acute kidney injury.
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Mutations in the polycystin genes Pkd1 (encoding poly-cystin-1; PC1) and Pkd2 (encoding PC2) cause auto-somal dominant polycystic kidney disease (ADPKD),
the most common monogenic disease1. This is a multisystemic
disease associated with the development of focal cysts in the
kidney, liver and pancreas, as well as arterial structural anomalies
and hypertension. A two hit mechanism was proposed including
one inactivating germinal mutation and an additional event
affecting the level of expression of the second allele (somatic
inactivating mutation or a hypomorphic dosage effect)1. PC2 is a
member of the Transient Receptor Potential (TRP) ion channel
family (also called TRPP2) made of six transmembrane segments
with a pore (P) domain located between S5 and S62,3.
PC2 is targeted to the primary cilium and its ion channel
function within this tiny organelle protruding at the apical side of
tubular epithelial cells was recently demonstrated using patch
clamp recordings4,5. Ciliary PC2 of mouse inner medullary col-
lecting duct cells mainly conducts monovalent cations, as well
as calcium, is inhibited at negative potentials by high external
calcium concentration (IC50: 17 mM), but stimulated by a rise in
intracellular calcium (EC50: 1.3 μM)4,5.
PC2 is also retained in the endoplasmic reticulum (ER)
through a retention signal in its carboxy terminal domain6,7.
PC2 was shown to act as a calcium releasing channel activated
by cytosolic calcium (calcium-activated calcium release) at the
ER membrane7. An EF-hand domain in the cytoplasmic C ter-
minus is proposed to underlie activation of PC2 by cytosolic
calcium7–11. Single channel recordings of microsomes enriched
ER PC2 fused in planar lipid bilayers show a bell-shaped
dependence on cytoplasmic calcium, with a maximum opening
at 0.3 μM Ca2+7,10. Additional ﬁndings indicate that PC2 inter-
acts with the type I IP3R to modulate intracellular calcium
signaling12,13. Calcium ﬂowing through the IP3R is thought to
locally activate PC2, thus amplifying calcium release from the
ER12,13. Accordingly, calcium transients elicited by vasopressin in
LLC-PK1 cells were greatly enhanced and prolonged when PC2
was overexpressed7,10. Conversely, PC2 was also shown to lower
ER calcium concentration resulting in decreased IP3-dependent
responses14. ER-resident PC2 counteracts the activity of the cal-
cium ATPase by increasing passive calcium leak14. Accordingly,
knock down of PC2 in renal epithelial cells increases ER calcium
content14. However, a role for PC2 in ER calcium leak remains
controversial12. Thus, depending on the gating mode (calcium-
gated or leak) PC2 differentially inﬂuences IP3-dependent
responses7,14. What regulates PC2 gating at the ER is currently
unknown.
In the present report, we demonstrate in renal proximal con-
voluted tubule (PCT) cells, that the ER conserved transmembrane
protein TMEM33 interacts with PC2, enhancing its channel
activity over the whole physiological cytosolic calcium range in
ER liposomes fused to planar bilayers. Finally, we establish a
functional link between TMEM33 and acute kidney injury (AKI),
while Pkd2-dependent cystogenesis is independent of TMEM33.
Results
TMEM33 is in a complex with PC2 at the ER of PCT cells. Our
previous proteomic ﬁndings indicated a possible biochemical
interaction between PC2 and TMEM3315. TMEM33 was co-
puriﬁed with PC2 (73 peptides identiﬁed versus 0 peptide in
control mock conditions), together with IP3R3 and IP3R115. When
the C-terminal domain of PC2 was truncated (PC2–742X and
PC2–690X), the number of identiﬁed TMEM33 peptides dropped
(7 and 6 peptides, respectively). Co-immunoprecipitation experi-
ments performed in PCT cells conﬁrmed that TMEM33 is found
in a complex together with PC2 (Fig. 1a, b, Supplementary
Fig. 1a). PC2 was speciﬁcally immunoprecipitated with both
TMEM33-HA and HA-TMEM33 in stably complemented
TMEM33−/− cell lines conditionally expressing TMEM33 at levels
(TMEM33-HA/TOP1 and HA-TMEM33/TOP1: 0.55 and 0.15,
respectively when induced with DOX), comparable to its native
physiological expression in WT PCT cells (TMEM33/TOP1: 0.2)
(Supplementary Fig. 1a). Importantly, immunoprecipitation of
TMEM33-HA or HA-TMEM33 with native PC2 was speciﬁcally
observed with an anti-HA antibody, and not with control rat
IgG (Supplementary Fig. 1a). Again partial truncation of the PC2
C-terminal domain lowered the interaction with TMEM33
(Fig. 1a, b). Next, we used the LexA/B42 based Grow’n’Glow
yeast-2 hybrid system to further conﬁrm the interaction (direct or
indirect) between TMEM33 and PC2 (Fig. 1c). Interaction (i.e.,
yeast growth) was observed between the C terminus of TMEM33
and the N terminus of PC2, as well as between the N terminus of
TMEM33 and the C terminus of PC2 (Fig. 1c). Of note, TMEM33
N and C termini (as well as the yeast homologues) are predicted
to be both facing the cytosolic side16–18, although an alternative
topology was also proposed19. Thus, TMEM33 establishes a
complex molecular interaction with PC2 in renal tubular epithelial
cells. In PCT cells, we observed an obvious co-localization of
TMEM33-GFP with mCherry-PC2 at the ER membrane, using ER
tracker as a speciﬁc marker for the ER (Fig. 1d). HA-TMEM33
visualized in the complemented TMEM33−/− PCT cell line was
also co-localized with native PC2 at the ER (visualized by calnexin
staining; Supplementary Fig. 5a). Importantly, co-localization was
absent at the primary cilium (Fig. 1e). PC2 (red ﬂuorescence, alexa
594) is present at the primary cilium (deep red ﬂuorescence,
alexa 647), while in the same cells TMEM33 (EGFP) is absent
(although it is visible at the ER; Fig. 1d, e, Supplementary Fig. 5a).
TMEM33 mRNA, as detected by qPCR, is broadly expressed in
mouse tissues (as previously reported for PC220), including the
kidney (Supplementary Fig.1b). Abundance of TMEM33 in renal
tubule cells was conﬁrmed using a TMEM33 LacZ reporter
mouse line (Supplementary Fig. 1c).
Thus, TMEM33 is in a molecular complex with the ion channel
PC2 at the ER membrane, but is absent from the primary cilium.
In this report, we focused on the physiopathological function of
TMEM33 in the kidney. In the next section, we investigated
whether TMEM33 inﬂuences the regulation of intracellular
calcium homeostasis through its interaction with PC2.
TMEM33 diminishes IP3-dependent calcium transients. We
investigated the effect of TMEM33 knock-down on the release
of intracellular calcium in PCT cells. IP3-dependent ER calcium
release induced by purinergic stimulation in the absence of
extracellular calcium was signiﬁcantly enhanced when cells were
transfected with two different validated siRNAs directed against
TMEM33 (Fig. 2a, Supplementary Fig. 2a, Supplementary Fig. 2f,
g, Supplementary Fig. 3c, d). TMEM33 or PC2 knock-down or
knockout experiments were validated both at the mRNA (qPCR
experiments) and protein levels (Western blots)(Supplementary
Fig. 1d and 1g, Supplementary Fig. 2f-j). Of note, knock-down of
TMEM33 did not affect PC2 protein expression, and vice-versa
(Supplementary Fig. 2f-j). Conversely, TMEM33 overexpression
had the opposite effect (Fig. 2b). Accordingly, the capacitative
calcium entry induced by re-addition of extracellular calcium
during ATP stimulation was enhanced when TMEM33 was
knocked down, but lowered when TMEM33 was overexpressed
(Fig. 2a, b). Regulation of intracellular calcium homeostasis was
further studied in a conditionally complemented TMEM33−/−
PCT cell line (Fig. 2c, d). In this cellular model, we used a Tet-on
system allowing an inducible expression of TMEM33 (or
TMEM33-HA or HA-TMEM33 tagged) along with a Cherry
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ﬂuorescent reporter in the presence of doxycycline (DOX)(Sup-
plementary Fig. 2e). Control cells were the parental TMEM33−/−
PCT cell expressing the repressor together with a CD8 construct
retained in the ER (CD8ER)21 and treated with DOX, similarly to
the cell line expressing TMEM33 (Fig. 2d). We isolated a clone
with an inducible TMEM33 expression (i.e. in the presence of
DOX) comparable to the level found in the WT PCT cells
(Fig. 2c). Again, when TMEM33 expression was enhanced by
DOX addition, the peak ATP response elicited in the absence of
extracellular calcium was blunted, as well as the associated
capacitative calcium entry (Fig. 2c). Importantly, these effects
were absent in the control CD8ER complemented TMEM33−/−
PCT cell line (Fig. 2d). Strikingly, in PCT Pkd2−/− cells TMEM33
knock-down or overexpression failed to affect the ATP response
(Fig. 2e, f, Supplementary Fig. 1d, Supplementary Fig. 2b). These
ﬁndings indicate that TMEM33 impacts the regulation of intra-
cellular calcium homeostasis through PC2.
The SERCA inhibitor thapsigargin does not allow the
discrimination of selective changes in ER calcium content or
number/activity of ER leak calcium channels since both
parameters are linked14. However, the calcium ionophore
ionomycin in the absence of extracellular calcium allows the
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Fig. 1 TMEM33 interacts with PC2 at the ER membrane of PCT cells. a Co-immunoprecipitation of TMEM33 with PC2 in PCT cells when TMEM33 is pulled
down. A pathologic PC2 deletion mutant PC2–742X was also tested. b Same, but when PC2 is pulled down. Arrowhead indicates TMEM33 and the upper
band is non-speciﬁc. c Yeast two hybrid experiments indicating an interaction (direct or indirect) between TMEM33 and PC2. We used a yeast strain with
chromosomal LEU2 reporter gene harboring LexA operator binding sites. As a second reporter we used GFP under the control of the LexA operator (URA).
The bait was either the COOH or NH2 terminus of TMEM33 expressed in frame with LexA (HIS), and the prey was either the COOH or NH2 terminus of
PC2 expressed in frame with B42. As a further selection the prey product is only expressed in the presence of galactose. For a positive interaction, the
yeast need to grow on medium -HIS-TRP-URA-LEU+Galactose and light up positive for GFP. As a positive control we used LexA-p53 with B42-LTA. As
negative controls, we either expressed the LexA-CtermTMEM33 with the empty prey vector or B42-CtermPC2 with the empty bait vector. No growth was
observed with any combination of either prey alone or bait alone. d Top: Co-localization of TMEM33-GFP (green) and mCherry-PC2 (red) in PCT cells;
Middle: co-localization of TMEM33-GFP (green) with ER tracker as an ER marker (red); Bottom: co-localization of mCherry-PC2 (red) with ER tracker
(green). The merged image (yellow shows co-localization) is shown at the right. False colors were used to consistently illustrate co-localizations in yellow
(ER tracker blue). The scale bar corresponds to 20 μm. e TMEM33 is absent at the primary cilium, unlike PC2. Acetylated-tubulin in red labels the primary
cilia and TMEM33 (top panels) or PC2 (bottom panels) are labeled in green (false colors). Co-localization of PC2 and acetylated tubulin is seen in yellow
(merged image; bottom panels). The right panels are magniﬁcation of the boxed area shown in the left panels. Arrows indicate primary cilia. The scale bar
corresponds to 15 μm. Source data are provided as a Source Data ﬁle
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precise measurement of stored intracellular calcium content14.
Notably, TMEM33 knock-down signiﬁcantly increased the release
of calcium from intracellular stores induced by ionomycin in a
PC2-dependent manner (Fig. 2g, h). A similar ﬁnding was
obtained with the conditional TMEM33 cell line, although not in
the parental CD8 expressing TMEM33−/− cell line (Supplemen-
tary Fig. 3a, b). Thus, our ﬁndings indicate that TMEM33
controls intracellular calcium homeostasis through PC2. Next,
we investigated whether TMEM33 affects the gating of ER PC2.
TMEM33 stimulates PC2 calcium-dependent activity. PC2 is
strongly upregulated in both acute and chronic kidney
diseases22–24. In light of these ﬁndings, we investigated the effect
of PC2 overexpression in PCT cells. When PC2 was transiently
overexpressed, an increase in basal cytosolic calcium was con-
sistently observed (Fig. 3a). Moreover, PC2 overexpression
mildly reduced the peak ATP response (Fig. 3b). Notably, in this
condition when TMEM33 was knocked down, the basal level
of cytosolic calcium became normalized (Fig. 3a). Again, in
PCT cells overexpressing PC2, an increase in the ATP response
was detected upon TMEM33 knock-down (Fig. 3b). Similar
ﬁndings were obtained with a PCT cell line stably overexpressing
PC2 (Supplementary Fig. 3c, d). These results are consistent with
a stimulation of PC2 opening by TMEM33. To directly test
this idea, we fused ER enriched microsomes of PCT cells over-
expressing PC2 in planar lipid bilayers and electrophysiologically
recorded channel activity7. Ba2+ was used as the charge carrier
on the trans (luminal) side, as it does not affect channel activity
on either side of the channel and permeates PC27. The open
channel probability showed a bell-shaped dependence on cyto-
plasmic calcium with a maximum observed at 0.3 μM, as pre-
viously reported10 (Fig. 3c, d). When TMEM33 was co-expressed
with PC2, we observed a prominent increase in channel open
probability across the entire activating calcium range, with no
signiﬁcant change in single channel current amplitude (Fig. 3c, d).
The decrease in channel activity expected at the higher calcium
range with PC2 alone was absent when TMEM33 was over-
expressed (Fig. 3d). Thus, TMEM33 modulates the gating of
PC2 by cytosolic calcium, removing channel inactivation at the
higher cytosolic calcium concentrations.
IP3R activation drives the calcium reﬁlling of other cellular
organelles, including lysosomes25–27. Next, we investigated
whether TMEM33 might indirectly inﬂuence endolysosomal
calcium content because of an altered IP3 calcium signaling.
TMEM33/PC2 impacts endolysosomal structure and function.
Both TMEM33-HA and HA-TMEM33, as well as native PC2
are found at the ER membrane (Fig. 1d, Supplementary Fig. 5a),
but are also detected within lysosomes (Supplementary Fig. 5b, c).
We found several lines of evidence that suggest a key role for
the ER TMEM33/PC2 complex on endolysosomal structure
and function. First, endosomes expressing Two-pore channel 1
(TPC1), as well as lysosomes expressing TPC2 were found in close
proximity to the ER (Supplementary Fig. 4a, b). Second, we mea-
sured the amount of calcium stored in lysosomes using the lyso-
somotropic agent glycyl-L-phenylalanine 2-naphthylamide (GPN)
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Fig. 2 TMEM33 regulates intracellular calcium homeostasis. a Increases in cytosolic calcium concentration are expressed as ratios of 340:380 nm
ﬂuorescence signals (ΔR/R0). ΔR is the ﬂuorescence ratio (340 nm/380 nm) measured at a given time divided by the initial ratio at time 0 (R0).
Transfection of PCT cells with two siRNAs directed against TMEM33 increases ATP calcium transients recorded in the absence of extracellular calcium,
as compared to the control non-targeting siRNA condition (siNT, n= 684, black symbols; siTMEM33–1, n= 589, red symbols; siTMEM33–2, n= 649,
magenta symbols). Re-addition of extracellular calcium during the ATP stimulation elicits a capacitative calcium entry. b Same in PCT cells transiently
overexpressing TMEM33 or not (Cherry, n= 244, black symbols; TMEM33, n= 254, green symbols). c Same in a conditional PCT cell line expressing
TMEM33 when induced with DOX (black trace; n= 321) or not (gray trace; n= 464). d Same in a conditional PCT line expressing CD8ER in the presence
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(siNT, n= 1648; siTMEM33–1, n= 11615; siTMEM33–2, n= 1587). h Same in Pkd2−/− PCT cells (siNT, n= 627; siTMEM33–1, n= 769; siTMEM33–2, n=
659). Values are means ± SEM. One star indicates p < 0.05, two stars p < 0.01 and three stars p < 0.001, with a Student’s t test used to evaluate statistical
signiﬁcance. Source data are provided as a Source Data ﬁle
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(Fig. 4a, b). Strikingly, TMEM33 signiﬁcantly attenuated the
amplitude of the GPN response in TMEM33 conditional PCT cells,
unlike in parental TMEM33−/− PCT cells expressing CD8ER
(Fig. 4a, b). Moreover, the effect of TMEM33 expression on lyso-
somal calcium load was suppressed when PC2 was knocked down
(Fig. 4c, d). Third, TMEM33 expression produced an increase in
the size of endolysosomes (Supplementary Fig. 4c–f). Fourth,
TMEM33 conditional expression increased cytosolic, as well as
extracellular cathepsins or N-acetyl-beta-D-glucosaminidase
(NAG) (Supplementary Fig. 6). Cleavage of the ﬂuorogenic cathe-
psin B/L substrate was detected when added to non-permeabilized
cells, but not when added to cell-free conditioned media, suggesting
that the extracellular activity of lysosomal cathepsins was due to
membrane-associated proteases. Notably, the effect of TMEM33 on
cathepsins or NAG translocation was markedly enhanced by
tunicamycin (TM) treatment that causes ER stress (Supplementary
Fig. 6). Remarkably, altered translocation of cathepsins or NAG
upon TMEM33 expression was again blunted by knocking down
PC2 (Fig. 4e-g; Supplementary Fig. 7). By contrast, overexpressing
PC2 had the opposite effect (Fig. 4e-g; Supplementary Fig. 7).
Altogether these ﬁndings suggest that the decrease in IP3
signaling mediated by TMEM33 impacts lysosomal size and
function in a PC2-dependent manner. Next, we investigated
whether TMEM33/PC2 might also inﬂuence the lysosomal
degradation pathway of autophagy.
TMEM33 inhibits autophagic ﬂux upon ER stress. Recent
studies indicate that PC2 stimulates autophagy in a variety of cell
types, including renal epithelial cells, as well as cardiomyocytes,
involving both the primary cilium and intracellular calcium
stores28–31. LC3 is the most widely used autophagosome marker
because the amount of LC3 II (conjugated to phosphatidyletha-
nolamine) reﬂects the number of autophagosomes32. Degradation
of p62 is another classical marker to monitor autophagic activity
because p62 is selectively degraded by autophagy32. In PCT cells,
TM treatment greatly increased the amount of accumulated
LC3II and conversely induced a drop in p62 (Fig. 5a–f).
Remarkably, both TMEM33 and PC2 knock-down prevented
TM-dependent LC3II accumulation (Fig. 5a–d). These observa-
tions suggest that in renal epithelial cells TMEM33/PC2 links ER
Δ 0.2
50 s
**
***
***
***
***
ATP
* *
*
100
105
110
Empty PC2
C
yt
os
ol
ic
 r
es
tin
g 
C
a2
+
 le
ve
l (
%
)
si TMEM33-1
si TMEM33-2
si NT
si TMEM33-1
si TMEM33-2
si NT
95
b
a
0 Ca2+
c
O
C
1 s
1pA
O
C
C
0 μM Ca2+
0.1 μM Ca2+
10 μM Ca2+
PC2 PC2+TMEM33
d
[Free Ca2+] (μM)
**
*
**
PC2
PC2 + TMEM33
0.01 0.1 1 100.03 0.3 3
0
0.2
0.4
O
pe
n 
ch
an
ne
l p
ro
ba
bi
lit
y
Fig. 3 TMEM33 controls the calcium-dependent gating of PC2. a Increases in cytosolic calcium concentration are expressed as ratios of 340:380 nm
ﬂuorescence signals (ΔR/R0). Relative (to the siNT empty vector condition; black bar) basal cytosolic calcium levels in PCT cells transfected or not with
siRNAs against TMEM33 (red and magenta bars). The effect of PC2 overexpression (as indicated at the bottom of the graph) was also investigated (dark
blue bar, siNT and light blue bars: siTMEM33–1 and siTMEM33–2). Experimental points are available in the data source ﬁle. Numbers of cells analyzed are
indicated in Fig. 2 and (b) legends. b ATP-induced calcium transients in the absence of extracellular calcium (siNT, n= 2353; siTMEM33–1, n= 2437;
siTMEM33–2, n= 2201; siNT+ PC2, n= 262; siTMEM33–1+ PC2, n= 246, siTMEM33+ PC2, n= 322). Same cells as in (a). c PC2 channel activity
elicited with 0, 0.1 and 10 μM free calcium on the cis-side (cytosolic) in ER liposomes fused to planar bilayers (holding potential: 0 mV). As previously
reported, the slope conductance of the channel was 85 pS when PC2 was activated by cytosolic calcium7, 10. C indicates the closed state and O the open
state (dashed line). d Open channel probability of PC2 measured at increasing concentration of free cytosolic calcium (PC2: blue bars and PC2+ TMEM33:
green bars). Values are means ± SEM overlaid with dot plots for (d). One star indicates p < 0.05, two stars p < 0.01 and three stars p < 0.001, with a
Student’s t test for (a, b), as well as a Mann–Whitney test for (d) used to evaluate statistical signiﬁcance. Source data are provided as a Source Data ﬁle
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10045-y ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2024 | https://doi.org/10.1038/s41467-019-10045-y | www.nature.com/naturecommunications 5
stress to the regulation of autophagy. LC3II accumulation
induced by TM might be due to either a stimulated autophagic
ﬂux and/or to a decreased degradation of autolysosomes32.
Chloroquine (CQ), a lysosomotropic agent, which prevents
autolysosomal degradation, caused an accumulation of LC3II in
basal conditions, that was further enhanced by TMEM33
expression (Fig. 5e, f)32. However, when TM was present (which
by itself elevates LC3II), CQ-induced LC3II accumulation in
TMEM33 expressing cells was blunted (1.3 fold versus 2.6 fold in
the presence of DMSO; Fig. 5e, f). These ﬁndings indicate that
TMEM33 stimulates the autophagic ﬂux in basal conditions,
while it attenuates autolysosome degradation during TM-
mediated ER stress.
Lysosomal dysfunction and translocation of cathepsins have
been shown to initiate cell death33–35. Next, we explored whether
TMEM33 might inﬂuence PCT cell death, as a consequence of
altered lysosomal function.
TMEM33 sensitizes PCT cells to apoptotic cell death. PCT cells
from TMEM33−/− mice were transiently complemented using
plasmids encoding TMEM33 and/or PC2, along with a ﬂuor-
escent Cherry reporter (IRES construct). Cell viability was
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estimated by counting the number of Cherry positive cells using
a cell sorter and normalized to the control CD8ER condition
(Fig. 6a). TMEM33 signiﬁcantly lowered cell viability when
transfected in a TMEM33−/− background (Fig. 6a). Remarkably,
in Pkd2−/− PCT cells this effect was absent, although the
effect was recovered when PC2 was also complemented (Fig. 6a).
In addition, the number of DAPI positive cells (as an index
of membrane permeabilization) was signiﬁcantly enhanced when
TMEM33 was expressed in TMEM33−/−, unlike in Pkd2−/− cells
[unless PC2 was complemented] (Fig. 6b). Of note, neither the
number of annexin V positive cells nor caspase activity was
signiﬁcantly enhanced by TMEM33 expression in TMEM33−/−
cells (Fig. 6c, d).
Next, we used an in vitro model of PCT cells ER stress
induced by TM (1 μg/ml; 16 h)36,37. In the conditional
TMEM33 expressing PCT cell line, DOX addition induced a
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time-dependent (over 96 h) increase in basal and TM-induced
release of lactate dehydrogenase (LDH; an index of cytotoxicity),
unlike in CD8ER expressing cells (Fig. 6e). LDH release from the
TMEM33 expressing cell line in the absence of DOX induction is
likely to be related to the leakiness of the repressor system and to
the basal TMEM33 expression (TMEM33/TOP1: 0.06+ 0.002)
occurring even in the absence of DOX, corresponding to about
10% of the cortical level of TMEM33 (Supplementary Fig. 9a).
Caspase 3/7 activity was not signiﬁcantly inﬂuenced by basal
TMEM33 expression, although it was strongly enhanced by
TM treatment in TMEM33 expressing cells (Fig. 6f). Finally,
cathepsins inhibition by leupeptin (LEUP) signiﬁcantly protected
PCT cells expressing TMEM33 from TM-induced LDH leakage,
indicating lysosomal dysfunction and contribution of cathepsins
(Fig. 6g).
Altogether, these ﬁndings indicate that TMEM33 expression
causes cytotoxicity (as detected by an increase in LDH leakage
and DAPI staining, as well as decreased cell viability) of PCT cells
and markedly enhances TM-induced apoptosis. Importantly,
the cytotoxic effect of TMEM33 was critically dependent on the
presence of PC2.
Next, we investigated in vivo whether TMEM33 might
similarly exert a deleterious effect on renal tubular cells in
conditions of AKI.
TMEM33 deletion confers renal protection against AKI. We
took advantage of a constitutive TMEM33 knockout (KO)
mouse model and focused on the renal function of TMEM33,
speciﬁcally investigating sensitivity to AKI. Homozygote mice
were viable, breeding and basal physiological parameters were
similar to wild type (WT) mice (Supplementary Tables 1 and 2).
In aged mice, over 1 year old, we saw no evidence for morpho-
logical anomalies, including the presence of renal cysts (Supple-
mentary Fig. 8). Expression of various ER stress related genes
in cortical tissues, including GRP78 and CHOP were unchanged
in the KO model (Supplementary Fig. 10). Moreover, renal
expression of PC2 was not altered in the KO mice (Supplemen-
tary Fig. 9e). Mice were subjected to AKI using the in vivo
TM toxicity model37,38. Following IP injection of 2 mg/kg TM,
about 20% of the WT mice died within 3 days (Fig. 7a, top panel).
However, all KO mice survived, despite the fact that the loss
in body weight induced by TM injection was identical between
both mouse lines (Fig. 7a, top and bottom panels). Of note,
the level of TMEM33 expression that is about twice as much
in mouse cortex, as compared to the medulla was unaltered in
the model of TM-induced AKI (Supplementary Fig. 9a, b).
Moreover, the pattern of TMEM33 expression (as visualized by
the LacZ reporter) in proximal or distal tubular segments was
not visibly altered upon TM treatment (Supplementary Fig. 9c, d).
In addition, expression of Pkd2 or TRPV4 (a partner of PC2
at the primary cilium39), was unchanged in the KO without or
withTM treatment (Supplementary Fig. 2c, d). Expression of
GRP78 and CHOP in the cortex was monitored at 12 and 72 h
post TM injection (Supplementary Fig. 10). Both genes peaked
at 12 h post injection and subsequently declined at 72 h. We
observed no signiﬁcant difference in the expression of either ER
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stress genes between WT and KO mice injected with TM (Sup-
plementary Fig. 10). NGAL/LCN2 (neutrophil gelatinase-
associated lipocalin) is routinely used clinically as an early bio-
marker for AKI40. We observed that LCN2 mRNA and protein
expression at 72 h post TM injection was signiﬁcantly decreased
in the cortex of KO mice (Fig. 7b–d). A similar effect was found
in the medulla, despite major differences in LCN2 mRNA and
protein expression levels (about 10-fold higher mRNA level, but
5-fold less protein in the medulla), as seen with two separate
antibodies (Fig. 7d and Supplementary Fig. 9f). Next, we esti-
mated the number of apoptotic cells on renal sections using
TUNEL staining (Fig. 7e, f). There was no signiﬁcant difference
in basal apoptosis when comparing vehicle injected WT and KO
mice. However, in TM-injected mice the cortical increase in
apoptotic cell death, as well as caspase 3/7 activation, was blunted
in kidneys from KO mice (Fig. 7e–g). These ﬁndings were con-
ﬁrmed using Periodic acid-Schiff (PAS) staining and morpholo-
gical analysis of kidney sections (Fig. 7h, i). No evidence of renal
cysts was found with (n= 12 and 13, for WT and KO, respec-
tively) or without TM treatment (n= 4 and 2 for WT and KO,
respectively). Grade 2 cortical lesions in TM-injected mice,
characterized by massive tubular dilatation, were reduced by
about half in the KO mice (Fig. 7h, i). Thus, a signiﬁcant pro-
tection against TM-induced AKI is observed in the TMEM33
KO mice. In summary, our ﬁndings indicate that TMEM33 plays
an important role in renal tubular cell vulnerability associated
with AKI.
Does TMEM33 exert a protective effect against cystogenesis?
It is now well established that reduced PC1/PC2 function (i.e.
dosage) causes ADPKD1. However, the relative contribution of
PC2 at the primary cilium and/or at the ER in the pathology
remains unclear at this stage. An important question is whether
or not TMEM33 (a selective activator of PC2 at the ER, but not at
the primary cilium) might exert a protective effect against Pkd2-
dependent cystogenesis. In other words, does TMEM33 invali-
dation aggravate cyst formation caused by Pkd2 knock-down and
can we probe the functional role of ER PC2 in renal cystogenesis
taking advantage of its activator TMEM33? It is important to
note that a protective effect of TMEM33 would not be expected
if Pkd2 is fully invalidated (homozygote knockout), since
TMEM33 could not enhance PC2 channel opening (Fig. 2e, f).
Exploring these questions in mice is technically challenging as
a Pkd2 hypomorphic model together with a targeted deletion of
TMEM33 would need to be implemented (of note Pkd2+/− mice
are not cystic and constitutive Pkd2−/− is embryonic lethal41).
To circumvent this major difﬁculty, we instead turned to a more
amenable and validated zebraﬁsh model of renal cystogenesis
based on the injection of morpholino oligomers to knock down
pkd2 and recapitulate the molecular mechanism (dosage effect) of
ADPKD and induce renal cysts42. The zebraﬁsh pronephros is
composed of two nephrons with glomeruli fused at the midline
(Fig. 8a). In the zebraﬁsh ADPKD model, a translation blocking
morpholino oligomer complementary to the ATG of pkd2 (MO
pkd2) is injected into the embryos at the 1 cell stage, causing
a large dilation of the glomeruli (cysts) two days later42 (Fig. 8b).
Taking advantage of this powerful and accessible assay, we
compared the effect of pkd2 knockdown on glomerular enlarge-
ment (using the wt1b:EGFP ﬂuorescent marker) in WT zebraﬁsh
(tmem33+/+) and in a tmem33 mutant ﬁsh line43. Glomerular
size of tmem33+/+, tmem33+/− or tmem33−/− embryos injected
with control MO was identical (Fig. 8c). Importantly, enlarge-
ment of glomeruli (i.e. cysts) induced by pkd2 MO was not
signiﬁcantly different in tmem33+/− or tmem33−/− embryos, as
compared to WT embryos (Fig. 8c).
Discussion
In this report, we demonstrate that TMEM33 is found in a
complex together with the ER channel PC2 in PCT cells. Deletion
of TMEM33 enhances IP3-dependent calcium signaling, whereas
its overexpression has the opposite effect. Strikingly, these effects
on the regulation of intracellular calcium homeostasis critically
depend on PC2. TMEM33 promotes PC2 channel opening
over the whole cytosolic calcium range in lipid bilayer ER lipo-
somes reconstitution experiments. Inhibition of IP3 signaling by
TMEM33 lowers calcium reﬁlling of endolysosomes, causing
lysosomal enlargement, cathepsins translocation and impaired
autophagic ﬂux during ER stress. Moreover, TMEM33 enhances
TM-induced PCT cytotoxicity in vitro that is prevented by
cathepsins pharmacological inhibition. In line with these ﬁndings,
genetic deletion of TMEM33 exerts a signiﬁcant protection in a
mouse model of TM-induced ER stress. Thus, TMEM33 inﬂu-
ences the regulation of intracellular calcium homeostasis in kid-
ney tubular epithelial cells and is associated with enhanced
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susceptibility to AKI, while it does not affect pkd2-dependent
renal cystogenesis.
TMEM33 is a transmembrane protein that is conserved during
evolution. There are two isoforms in the budding yeast S. cere-
visiae called Pom33 and Per3316. Pom33 is present at the ER and
is also dynamically associated with the nuclear pore complex,
unlike Per33 that is restricted to the ER16. Pom33 contributes to
the distribution and/or assembly of nuclear pores16,44. The ﬁssion
yeast TMEM33 protein (called Tts1) also functions in organizing
peripheral ER and in remodeling the nuclear envelope during
mitosis17,18. It is predicted that TMEM33 is made of one trans-
membrane segment followed by a hairpin in which hydrophobic
segments do not fully span the membrane, with both N and C
termini facing the cytosol16. The C-terminal amphipathic helix
in Tts1 plays a key role in ER shaping and modulating the
mitotic nuclear pore complex distribution17. In addition, Tts1/
Pom33 might function to sustain the highly curved ER domains
in interaction with the reticulons Rtn1 and Yop116–18. In mam-
malian cells, TMEM33 was similarly characterized at the ER
membrane as a Rtn-binding protein19. Interestingly, TMEM33
has the ability to suppress the membrane-shaping activity of
Rtns, thereby inﬂuencing the ER tubular structure19. In addition,
TMEM33 was identiﬁed as a participant in US2-mediated
degradation of MHC I45. Moreover, TMEM33 was shown to
be a stress-inducible ER protein that modulates the unfolded
protein response signaling by interacting with PERK and IRE1α
in cancer cells46.
The in vivo physiopathological function of mammalian
TMEM33 remained to be determined. Here, we demonstrate that
TMEM33 is a key modulator of intracellular calcium homeostasis
through the regulation of PC2 at the ER, inﬂuencing AKI in the
mouse. Unexpectedly, we found that TMEM33 expression dra-
matically alters the calcium-dependency of PC2 in ER liposomes
fused to planar bilayer. Increasing cytosolic calcium typically
produces a bell-shaped increase in the open channel probability
of PC2, indicating the overlapping inﬂuence of both a stimulatory
(at the lower calcium range) and an inhibitory calcium-dependent
mechanism (at the higher calcium range)7,10. When TMEM33
is overexpressed, the inhibitory mechanism disappears, thus
resulting in a net stimulation of channel activity over the entire
physiological calcium range. Our data are consistent with the fact
that enhanced PC2 channel opening in the presence of TMEM33
results in ER calcium depletion and diminished IP3 responses, in
line with a previously reported role for PC2 as a leak calcium
conductance of the ER14. Thus, our in vitro experiments
demonstrate that TMEM33 is a major regulator of ER PC2 gating
(i.e. acting as an auxiliary subunit), promoting its opening over
the whole cytosolic calcium range. Our ﬁndings further validate
PC2 as an ER calcium release channel7,12,14.
Acidic organelles are coupled to the ER through calcium
microdomains at membrane contact sites. ER calcium content
and IP3R-evoked calcium release are proposed to control the
uptake of calcium in lysosomes26,27,47. We observed that endo-
lysosomal calcium load is reduced by TMEM33, along with
diminished IP3 responses. Endolysosomal size and translocation
of cathepsins is enhanced by TMEM33. We propose that altered
lysosomal calcium reﬁlling through impaired IP3-dependent sig-
naling is a major contributor to these anomalies. Previous ﬁnd-
ings indicated that larger lysosomes are more susceptible to
breakage and release of their contents48. Thus, lysosomal leaki-
ness induced by TMEM33 might possibly be related to the
increase in their size.
The effect of TMEM33 on the regulation of intracellular cal-
cium homeostasis shown in vitro is critically dependent on PC2.
Similarly, TMEM33-induced translocation of cathepsins was
greatly inﬂuenced by PC2. In addition, the cytotoxic effect of
TMEM33 was again dependent on PC2. However, we cannot rule
out that some of the TMEM33 effects might be PC2-independent.
TMEM33 was previously linked in various cell types to different
mechanisms, including tubulation of the ER, nuclear pore
assembly and distribution, protein degradation or ER stress
responses (see above). Thus, it is possible that these mechanisms
might also be at play in the kidney. For instance, previous ﬁnd-
ings demonstrated that TMEM33 interacts with Rtns in both
yeast and mammalian cells, inﬂuencing ER tube caliber16–19.
Whether or not TMEM33 might inﬂuence PC2 and/or IP3R
activity through a change in local ER membrane curvature is a
possibility to be considered. Moreover, changes in membrane
curvature may also impact endolysosomal morphology and
ability to form membrane contact sites at the ER. Notably,
ER/endosome contact also regulates maturation and ﬁssion of
endosomes49,50. Thus, disruption of ER/lysosome contact may
be an additional explanation for depletion of lysosomal calcium
content. In this context, TMEM33 might also act as a negative
regulator of membrane contact sites between the ER and the
endolysosomes.
In the human breast cancer cell line MCF-7, TMEM33 inter-
acted and stimulated both the PERK/p-eIF2α/ATF4/CHOP and
IRE1α-XBP1-S signaling pathways46. However, the present ﬁnd-
ings indicate that TMEM33 sensitizes PCT cells to TM-induced
apoptosis, independently of a change in the ER stress response.
Instead, our study indicates that kidney lysosomal dysfunction,
including translocation of cathepsins contribute to the cytotoxic
effects of TMEM33. Thus, renal tubular epithelial cells and breast
cancer cells show a different susceptibility to the deleterious
effects of TMEM33 expression, with the possible differential
involvement of cell cycle components or other elements that
contribute to cancer46.
Clearly, future studies will be required to identify all the
mechanisms at play (including those independent of PC2) in
the renal effects of TMEM33. Nevertheless, the present work
already brings strong evidence that TMEM33 might behave
as an auxiliary regulatory subunit of ER PC2 in PCT cells,
acting as a gating activator (at least demonstrated in vitro in
the present report). In mammary breast cancer cells, TMEM33
mRNA and protein expression are greatly enhanced by thap-
sigargin or TM treatments46. In the same line, it is interesting
to note that during ischemic acute renal failure, affecting
primarily the proximal tubule, a pronounced upregulation of
intracellular PC2 (the partner of TMEM33) was reported22–24.
The upregulation of PC2 might act as a brake on cell pro-
liferation (acting in part as a tumour suppressor gene) to allow
the proliferative index of the ischemic kidney to return to
baseline23. Accordingly, the magnitude and duration of tubular
and interstitial proliferative responses was enhanced in injured
Pkd2+/− mice51.
Dysregulation of cathepsins expression/activity is associated to
the onset and progression of various kidney diseases, including
AKI34. For instance, cathepsin D is increasingly recognized as
a key driver of apoptosis during AKI52. In addition, translocation
of cathepsins from the lysosome into the cytoplasm was
demonstrated as an important event involved in renal physio-
pathology53. Thus, the previously reported multifaceted role of
cathepsins in kidney disease is clearly in line with the present
study34.
Autophagy is triggered upon stress to eliminate excess proteins
and protects cells against metabolic damage54–58. It has been sug-
gested that increased [Ca2+]cyt/[Ca2+]ER, at least partly, contributes
to the stimulation of autophagy59. Recent ﬁndings indicate that in
cardiomyocytes, PC2 functions to promote autophagy under glu-
cose starvation or mTOR (target of rapamycin) inhibition29,31.
Knockdown or knockout of PC2 reduced the autophagic ﬂux, while
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PC2 overexpression had the opposite effect29,31. PC2-induced
autophagy in cardiac cells was blunted by intracellular calcium
chelation, whereas removal of extracellular calcium had no effect29.
These ﬁndings suggest a model whereby PC2-dependent regulation
of autophagy occurs through the regulation of intracellular calcium
homeostasis29,31 (Fig. 9a). Previous ﬁndings also indicated that
TMEM33 overexpression in cancer cells results in a stimulation
of autophagy46. Similarly, in the present study we observed an
enhancement of the autophagic ﬂux of PCT cells by TMEM33 in
the basal conditions (Fig. 5a–f). Activation of ER PC2 by TMEM33
at least partly contributes to this effect (Fig. 5c and Fig. 9a). By
contrast, upon TM-induced ER stress we observed an impaired
autophagic ﬂux when TMEM33 was expressed, likely due to lyso-
somal dysfunction (Fig. 5e, f, Fig. 9b).
Altogether, our ﬁndings suggest that TMEM33 is an impor-
tant, so far unrecognized player in AKI. In basal conditions,
TMEM33 overexpression does not induce signs of apoptosis
(as detected by caspase 3/7 activity or TUNEL staining).
Rather, we show that TMEM33 sensitizes PCT cells to apoptosis
during ER stress. We propose a mechanistic model addressing
the scenario of AKI, including a possible role of TMEM33/
PC2 in cathepsins translocation and impaired autophagic
ﬂux upon ER stress (Fig. 9b). Accordingly, deletion of TME-
M33 exerts a potent protective role against TM toxicity
(Fig. 7).
Since TMEM33 acts as an activator of PC2, at least in vitro,
we investigated whether or not it might exert some beneﬁcial
effects against Pkd2-dependent cystogenesis. Using a pkd2
hypomorphic model (dosage) of ADPKD in the zebraﬁsh, we
found no signiﬁcant protection of TMEM33 against pkd2-
dependent renal cystogenesis. These ﬁndings indicate that ER
PC2 might not be causal to ADPKD, but rather a loss-of-function
of PC2 at the primary cilium (that does not interact with
TMEM33) is responsible for cystogenesis, as already indicated
by the tight association between renal cystic diseases and
numerous ciliopathies60.
In conclusion, our in vitro work shows that TMEM33 acts
as a gating activator of ER PC2. Moreover, our in vivo studies
suggest that TMEM33 is involved in AKI, while it does not
inﬂuence renal cystogenesis, at least in the zebraﬁsh.
Methods
Cell culture. PCT cells were derived from mouse kidneys and primary cultures
were immortalized with pSV3NEO61. Cells were grown in DMEM/F12 (V/V)
medium, containing 1% FBS, 15 mM NaHCO3, 2 mM glutamine, 20 mM HEPES,
5 mg/l insulin, 50 nM dexamethasone, 10 µg/l EGF, 5 mg/l transferrin, 30 nM
sodium selenite, 10 nM T3 (triiodo-L-thyronine) and 125 µg/ml G418 (geneticin).
PCT Pkd2−/− cells62 (a kind gift from Steve Somlo) were grown in DMEM/
HAMF12 (V/V) medium, containing 3% FBS, 7.5 nM Na selenite, 1.9 nM T3
(triiodo-L-thyronine), 5 mg/l insulin, 5 mg/l transferrin, 50 U/ml nystatin, 10 U/ml
INF (interferon-gamma) and 100 μg/ml penicillin/streptomycin at 33 °C in a
humidity-controlled incubator with 5% CO2. HeLa cells (a kind gift from Valérie
Doye;16) were cultured in DMEM containing 10% FBS and 100 μg/ml penicillin/
streptomycin. For HeLa stably expressing GFP-TMEM33 1 mg/ml of G418
was added.
Plasmid constructs. The following plasmids were used in this study: pIRES2-
EGFP PC2 (#32), pIRES2-EGFP TMEM33 (#212), pBUD mCherry-PC2 (#250),
pBUD 1.mCherryPC2 2.EGFPTMEM33 (#255), pIRES-puro3 HA-PC2 (#203),
pBUD 1.TMEM33iresCherry 2.PC2 (#438), pBUD 1.CherryiresCherry 2.PC2
(#439), pBUD 1.TM33iresCherry 2.CD8ER (#440), pBUD 1.CherryiresCherry 2.
CD8ER (#441). pCDNA3.1 CD8-ER (I-II loop Cava 1 A)-Myc (#437). pCMV
Myc-PC2 (#113), pCMV Myc-742X (#116), pcDNA3.1 Myc-TMEM33 (#217),
pcDNA3.1 HA-PC2 (#179), pcDNA3.1 HA-742X (#180), pcDNA3.1 TMEM33-HA
(#177), pCDNA3,1 zeo (+ )mCherry -PC2 (# 253), pEGFP-N1 -TMEM33 (#106).
Samples and maps are available on request.
TMEM33 knockout mice. ES cells heterozygous for TMEM33 (Tmem33 tm1
(KOMP)Mbp) were purchased from the KOMP (Knockout Mouse Project) repo-
sitory UC Davis, CA, USA. The construct contains a synthetic cassette including
LacZ, inserted in intron 2–3 and deleting coding exons 3, 4, 5 and 6 (Supple-
mentary Fig. 11). The remaining exons encode 27 amino acids of which 15 cor-
respond to the predicted cytosolic amino terminus of TMEM33. TMEM33
knockout mice were generated using these ES cells at MRC Harwell, Oxford, UK.
Generation of stable cell lines using the T-Rex system. As a ﬁrst step,
immortalized PCT cells derived from (TMEM33−/−) KO mice were transfected
with pcDNA6TR (Tet repressor) linearized with FspI. Transfections were per-
formed in a 35 mm plate with 250 000 cells using 2 μg of plasmid and 5 μl of
Lipo2000 (Invitrogen) according to manufacturers instructions. After 48 h, cells
were dissociated with 250 μl trypsin and 750 μl of complete medium. The serum
used was TET system approved FBS (Clontech). 25 μl, 50 μl and 100 μl were then
seeded into 10 cm dishes with medium supplemented with 15 μg/ml blasticidin.
Individual clones were picked using cloning cylinders and ampliﬁed in a 6-well
plate. Each clone was tested by western blot to determine the best expression of the
Tet repressor using the Tetr antibody from Sigma. Clones were further tested using
the pcDNA4/TO lacz plasmid+ /− 1 μg/ml of DOX. Clone 34 was selected to
introduce pcDNA4/TO TMEM33iresCherry (#368). Transfections were carried out
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Fig. 9 TMEM33/PC2, intracellular calcium homeostasis and cell death. Schematic model describing the effect of TMEM33 on the regulation of intracellular
calcium homeostasis, lysosomal function, autophagic ﬂux and tubular cell death in control conditions (a) or upon ER stress (b). The proposed model (ﬁgure
created by EH) addresses the scenario of AKI (b), when TMEM33 expression is enhanced46 (right panel). Our ﬁndings indicate an interaction between
TMEM33 and PC2 at the ER membrane causing an increase in PC2 channel activity spanning the whole physiological calcium range. TMEM33 induces,
through PC2, a decrease in intracellular calcium and a diminished IP3 calcium signaling (right panel). Consequent decrease in the calcium reﬁlling of
lysosomes, associated with an enlargement and translocation of cathepsins sensitize PCT cells to TM-induced apoptosis. Moreover, impairment of
autolysosome degradation causes an inhibition of the autophagic ﬂux and a loss of cellular protection upon ER stress. Accordingly, genetic deletion of
TMEM33 in the mouse provides a signiﬁcant protection against TM-induced AKI. Source data are provided as a Source Data ﬁle
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with plasmid linearized with FspI. 48 h later 25 μl, 50 μl and 100 μl of dissociated
cells were seeded into 10 cm dishes with medium supplemented with 25 μg/ml
zeocin. A total of 24 clones were analyzed by qPCR after 48 h of induction. Despite
the presence of the Tet repressor, all the clones showed some leakiness in the
absence of DOX. Cl.34 R (Tetr) was selected to generate a control line expressing
pcDNA4/TO CD8-ER iresCherry. Similarly, cell lines were generated to express
either pcDNA4/TO TMEM33-HA (#367) and pcDNA4/TO HA-TMEM33 (#366).
Cell transfection. Transfections were performed using either JetPEI (Polyplus-
transfection) with a DNA:Lipid ratio of 1:2 or Fugene6 (Promega) with a ratio
of 1:4 or Viafect (Promega) with a ratio of 1:4 or Lipo2000 with a ratio of 1:2.5.
Cells were analyzed 48–96 h later.
Ready-to-use siTMEM33 and siPkd2 (20 nM siRNA) were transiently
transfected into different PCT cell lines, using the HiPerFect Transfection Reagent
(Qiagen SA, Courtaboeuf, France). Control siRNA experiments were performed by
transfecting non-Targeting siRNAs. Cells transfected with siRNA were used 48 h
later for mRNA extraction and 72 h for protein extraction and functional analysis.
Control siRNA were purchased from Dharmacon (siNT-1) and Invitrogen
(siNT-2), siRNA directed against TMEM33 were purchased from Invitrogen
(siTMEM33–1: 5′-GGCUGCAUCAGAGAUUACCUCACUU-3′) (siTMEM33–2:
5′-GGCUUUCUCGCCUGUUCACAGUUUA-3′). siRNA directed against Pkd2
were purchased from Dharmacon (siPKD2–1 5′-UCAUAGACUUCUCGGUGUA-
3′) (siPKD2–2 5′-UACGGGAGCUGGUCACUUA-3′). Validation of the siNRAs
against TMEM33 is shown in Supplementary Fig. 2a-b. Transfection rates of WT
(45%, n= 3) and TMEM33−/− (41%, n= 3) PCT cell lines were determined at 48 h
post transfection using siGLO transfected with RNAiMax using Cytation 5 Cell
Imaging Multi-Mode Reader.
Yeast two-hybrid system. The yeast two-hybrid system used allows the identi-
ﬁcation of molecular interactions within the nucleus (including cytosolic
fragments). Transformations were carried out according to the manufacturer’s
instructions (Mo Bi Tech). As a ﬁrst step, the pEG202 series of plasmids were
transformed individually into the EGY48 strain and plated onto glucose – HIS.
Colonies were then streaked onto glucose –HIS –LEU (to check for autoactivation).
Once autoactivation had been ruled out, the pJG4–5 series of plasmids were
transformed as shown in Supplementary Table 3.
Fragments cloned into pEG202 or pJG4–5 are as follows: TMEM33 N term
(amino acids 1–24), TMEM33 C term (amino acids 197–248), PC2 N term
(amino acids 1–222) and PC2 C term (amino acids 677–968)
These transformations were plated onto glucose – HIS– TRP subsequently
streaked onto gal/raf –HIS–TRP–LEU. Clones that grew on these plates were then
veriﬁed for galactose dependence by a drop test. Brieﬂy, yeast were inoculated into
35 µL of 0.9% NaCl. Either 3 µL was spotted onto glucose–HIS–TRP–LEU or
gal/raf –HIS–TRP–LEU, a 10-fold dilution was similarly spotted. Real positives
were selected on the basis of growth on galactose/rafﬁnose. The prey (pEG202) and
bait (pJG4–5) vectors, as well as the yeast (EGY48 strain) were purchased from
MoBiTech. The YPDA medium and the DropOut (DO) supplemented mediums
were purchased from Clontech.
qPCR. Total RNA was isolated using RNeasy mini kit (Qiagen) and equal amounts
of cDNA were synthesized using the SCIII reverse transcriptase (Invitrogen).
Primer sequences used for quantitative PCR (qPCR) analysis are listed in
Supplementary Table 4.
Western blots. PVDF membranes (Perkin Elmer) were saturated in PBS 0.1%
Tween and 5% non-fat milk then incubated overnight with diluted primary anti-
bodies. After 3 × 15 min washes in PBS 0.1% Tween, secondary antibodies con-
jugated to HRP were added at a dilution of 1:30,000 (Jackson) and incubated for a
minimum time of 1 h. After several washes, the membranes were processed for
chemiluminescent detection using the Super Signal West Pico chemiluminescent
substrate (Pierce), according to the manufacturer’s instructions for detection of
Calnexin or GAPDH. Western Lightning ECL Ultra (Perkin Elmer) was used when
signals could not be detected using the pico substrate. The membranes were then
exposed using the Fusion FX (Vilber Lourmat). The intensity of the signals was
evaluated by densitometry and semi-quantiﬁed as the intensity of band corre-
sponding to the protein of interest divided by the intensity of the band corre-
sponding to GAPDH, tubulin, actin or calnexin for each experiment. Each
experiment presented was repeated at least twice. Uncropped versions of all blots
are available within the Source Data ﬁle.
Immunoprecipitations. Cells were seeded at 500,000 in 60 mm plates the day
before transfection. Transfections were performed in duplicate with 2.5 μg of each
plasmid using either JetPEI or Lipo2000. 2 plates per transfection were harvested
48–72 h later in 1 ml NEB lysis buffer (150 mM NaCl, 10 mMTris.Cl pH7.4, 1 mM
EDTA, 1 mM EGTA, 1% TritonX100, 0.5% NP40 supplemented with Roche Ultra
protease inhibitors, PefablocSC, Phosphatase inhibitors). The samples were
sonicated and then rotated in the cold room for 30 minutes, before centrifugation
at 4 °C for 10 minutes at 20,000 × g. A concentration of 20 μg of protein was
removed for input analysis. Equivalent quantities of protein were used for the
immunoprecipitations. To avoid detecting antibodies during the western blot, 2 μg
of antibody (anti-HA 3F10 Roche) was crosslinked to either Protein A or Protein G
magnetic beads (NEB) using dimethyl pimelimidate dihydrochloride (D8388
SIGMA). After 30 min preclearing, 25 μl of crosslinked beads were added to each
lysate and incubated with rotation in the cold room for a minimum time of 1 h.
Beads were washed 3Xs with NEB buffer. Proteins were released from the beads
using 25 μl of 0.1 M glycine pH2.5. 5 μl of 1 M Tris.Cl pH7.5 was added to neu-
tralize the acidity. Samples were charged with Laemmli loading buffer/β−mer-
captomethanol after heating at 70 °C for 10 min.
Antibodies. Antibodies used in this study, as well as dilutions are listed in
Supplementary Table 5.
Lysosomal preparation. Cells (TMEM33−/−, HA-TMEM33 and TMEM33-HA)
were seeded in 4 large 175 cm2 ﬂasks and grown to conﬂuence in the presence
of doxycycline for 72 h. Cells were trypsinized, spun down and rinsed with 1×
PBS- and resuspended in Lysosome Enrichment Reagent A complemented with
protease inhibitors. Lysosomes were then prepared according to the manufacturers
instructions (ThermoSCIENTIFIC cat. 89839). For western analysis, either 20 μg
of whole cell lysate or 2 μg of lysosomal lysates were loaded on a 4–15% gradient
gel (Criterion, Biorad). Blots were developed either with Western Lightning Ultra
(Perkin Elmer cat. NEL112001EA) or Western Lightning ECL Pro (Perkin Elmer
cat. NEL120001EA).
Intracellular calcium measurements. Cells were plated, at a density of 3000 cells/
cm2, on glass-bottom ﬂuorodishes (World Precision Instruments) coated with
collagen. Cells were loaded with 2 µM Fura-2 AM for 30 min. Loaded cells were
visualized under an inverted epi-ﬂuorescence microscope (AxioObserver, Carl
Zeiss, France) using a Fluar ×20. Then cells were continuously superfused with
control or test solutions at 37 °C using an automatic heater controller system
(TC-344B temperature/heater controllers, Warner Instrument Corporation,
Hamden, USA). The control solution contained (mmol/L): NaCl, 116; KCl, 5.6;
CaCl2, 1.8; MgCl2, 1.2; NaHCO3, 5; NaH2PO4, 1; HEPES, 20; glucose 1 g/l, pH 7.35.
The excitation light was supplied by a high pressure Xenon-arc lamp (Lambda LS,
Sutter Instrument Company, One Digital Drive, Novato, USA) and the 340 and
380 nm wavelengths were selected through a high-speed multi-ﬁlter wheel
(Lambda 10–3, Sutter Instrument Company, One Digital Drive, Novato, USA). For
each excitation wavelength, the ﬂuorescence emission was discriminated by a
400 LP dichroic mirror and a 510/40 bandpass ﬁlter. Fluorescence images were
collected every 2 seconds by an EMCCD camera (Cascade 512, Roper Scientiﬁc,
Evry, France). Images were digitized, and integrated in real time by an image
processor (Metaﬂuor, Princeton, NJ, USA). 340 and 380 background ﬂuorescence
signals were collected at the same rate and subsequently subtracted from respective
ﬂuorescent images. Results (ΔR/R0) were expressed as ratios between 340 and 380
ﬂuorescence signals measured during a response divided by the ratio measured in
resting conditions (that is, before the addition of an agent). Cells with increased
ΔR/R0, in response to different stimuli, were counted from ﬁelds containing 30 to
100 cells taken from 3 to 4 separate experiments. First, cells were superfused with
the control solution and then CaCl2 was omitted and 1 mM EGTA was added.
Agents (ATP 20 µM or GPN 250 μM) were added to the calcium free solution to
induce calcium release from the ER or ionomycin (5 µM) to estimate the amount
of intracellular calcium.
Confocal microscopy and immunohistochemistry. Cells were plated, at a density
of 3000 cells/cm2, on glass-bottom ﬂuorodishes (World Precision Instruments)
coated with collagen. Cells were transfected 48 h before imaging using Leica SP5
confocal microscope with a 63X objective. Nuclei were labeled with Hoechst
staining (blue). A TMEM33-EGFP construct was stably expressed in Hela cells.
Primary cilia were visualized with acetylated tubulin antibody (Sigma T7451;
1/200) and a secondary donkey anti-mouse antibody (Alexa 647 Invitrogen
A-31571; 1/500). ER was marked with ER Tracker blue (invitrogen E12353) and
lysosomes by Lysotracker red (invitrogen L7528).
Electron microscopy. Cells were ﬁxed in 1.6% glutaraldehyde in 0.1 M phosphate
buffer (pH7.4). They were rinsed with cacodylate buffer 0.1 M, then post-ﬁxed in
osmium tetroxide (1% in cacodylate buffer) reduced with potassium ferrycyanide
(1%) for 1 h. After a water wash, cells were dehydrated with several incubations in
increasing concentrations of ethanol and embedded in epoxy resin (EPON). Eighty
nanometer sections were contrasted with uranyl acetate (4% in water) then lead
citrate and observed with a Transmission Electron Microscope (JEOL JEM 1400)
operating at 100 kV and equipped with a Olympus SIS MORADA camera.
Gating strategies used for cell sorting. To ensure high purity of cells, a step-by-
step gating strategy was performed (Supplementary Fig. 12). Cells were separated
from debris by forward scatter (FSC) and side scatter (SSC) parameters. Using
FSC-width (FSC-W) versus FSC-height (FSC-H) and SSC-W versus SSC-H, single
cells were gated to avoid false positive signals produced by aggregates. Single cells
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were then gated as the mCHERRY+ population (living cells) from which DAPI+
and caspase+ (or annexin+ ) were further gated.
Caspase assay. A total of 50,000 cells were seeded in a 24-well plate with and
without 1 μg/ml DOX. The next day, cells were treated either with vehicle (DMSO)
or TM (1 μg/ml). 16 h later, cells were scraped into 50 μl of caspase lysis buffer
(1% TritonX100, 150 mM NaCl, 0.1 mM EDTA, 20 mM Hepes pH7.5, 1 mM
MgCl2, 5 μg/ml leupeptin, 10 μg/ml aprotinin, 0.1 mM pepstatin A) and incubated
on ice for 30 min. Lysates were centrifuged for 5 minutes at 4 °C at 20,000 × g.
Supernatants protein dosage was performed using the DC protein assay kit
(Bio-rad). 10 μg of protein was used in the assay in a ﬁnal volume of 100 μl.
Caspase-Glo® 3/7 Assay Systems (Promega) was used to quantitate caspase activity.
Flow cytometry caspase. Caspase activity was assayed using CellEvent Caspase-3/
7 Green ﬂow Cytometry assay kit (molecular probes). Cells were seeded in 6-well
plates at 250,000 per well the day before transfection. The cells were transfected
using 1.5 μg DNA and Lipo2000. After 72 h, supernatants were recuperated. A
concentration of 1 ml of accutase (Sigma) was added per well to recuperate the
cells. Cells were centrifuged for 5 min at 150 × g and the pellet was resuspended in
500 μl PBS- and centrifuged again. This step was repeated. Each pellet was resus-
pended in 250 μl complete medium supplemented with DAPI at (0.05 μg/ml) and
0.5 μl of CellEvent Caspase 3/7 Green detection reagent (ex. 511/ em. 533) and
incubated at 37 °C for 25 min. Cells were then sorted for mCherry (positive for
transfection), DAPI and Caspase activity.
Flow cytometry Annexin V. One of the earlier events of apoptosis includes
translocation of membrane phosphatidylserine (PS) from the inner side of the
plasma membrane to the surface. Annexin V, a Ca2+-dependent phospholipid-
binding protein, has high afﬁnity for PS, and ﬂuorochrome-labeled Annexin V can
be used for the detection of exposed PS. Cells were transfected as described above.
Supernatant and cells were recuperated as described above. Cell pellets were
resuspended in 100 μl of 1X binding buffer (10 mM Hepes/NaOH pH7.4, 140 mM
NaCl, 2.5 mM CaCl2). A concentration of 5 μl of Annexin V (Annexin-V-FLUOS,
Roche) and DAPI (0.05 μg/ml) were added and the sample was incubated for 15
min at RT. A concentration of 200 μl of binding buffer was added before sorting.
Cells were then sorted for mCherry (positive for transfection), DAPI and
AnnexinV binding.
LDH assay. LDH activity was determined using Cytotoxicity detection kit (LDH)
(Roche 11644793001). 50 000 cells were seeded in a 24-well plate with and without
1 μg/ml DOX. The next day, cells were treated either with vehicle (DMSO) or
TM (1 μg/ml). After 16 h, 250 μl of medium from each well was removed and
centrifuged at 250 × g for 10 min. A concentration of 100 μl of supernatant was
transferred in a 96-well ﬂat bottom microplate in duplicate and 100 μl of reaction
mixture was added to each well. After 30 minutes of incubation at room tem-
perature, absorbance was measured at 492 nm for LDH activity and at 600 nm for
background control (subtracted to the average value of the duplicate at 492 nm).
The percentage cytotoxicity was calculated according to the manufacturer’s
instructions.
Lysosomal enzyme activity assays. PCT cells were seeded into black-walled
clear-bottom 96-well plates (Grienier Bio-One) at a density of 3 × 104 cells per well,
in the presence or absence of 1 µg/ml DOX. Cells were cultured for 96 h as
described above. Pharmacological manipulations were made 8 h prior to testing
enzyme activities. For extracellular activity of lysosomal enzymes, substrates were
added to wells containing intact cells and conditioned cell culture media. Before
measuring cytosolic activity or total intracellular activity of lysosomal enzymes of
interest, cells were washed in PBS, and the plasma membranes of the cells were
permeabilized using 20 µg/ml digitonin, or cells were completely lysed using 200
µg/ml digitonin, respectively. Substrates were diluted into potassium phosphate
buffer, pH 5.5, and added to wells containing either permeabilized or lysed cells.
Cathepsin B and L activity was detected using the ﬂuorogenic cathepsin substrate
Z-Phe-Arg-AFC (Enzo Life Sciences), λex 310 ± 10 nm, λem 500 ± 10 nm. N-acteyl-
beta-D-glucosaminidase (NAG) activity was detected using the ﬂuorogenic sub-
strate, 4-Methylumbelliferyl N-acetyl-β-D-glucosaminide (Sigma Aldrich), λex 365
± 10 nm, λem 445 ± 10 nm. Cleavage of ﬂuorogenic substrates by lysosomal
enzymes of interest was monitored using a Tecan Inﬁnite M1000 Pro plate reader.
Substrate cleavage was monitored for 90 minutes at 37oC, and peak RFU values
were used for analysis of enzyme activity.
TUNEL assay. Terminal deoxynucleotidyl transferase (TdT)-mediated 2′-deox-
yuridine 5′-triphosphate-biotin nick-end labeling (TUNEL) staining was
performed by using the In Situ Cell Death Detection Kit (Roche, Mannheim,
Germany). Labeling of 3′-OH terminal DNA fragments was then performed
at 37 °C for 1 h by using the TUNEL reaction mixture according to the manu-
facturer’s protocol.
Mouse renal sections were rehydrated and incubated with Proteinase K for
15 min at 37 °C. Tissue auto ﬂuorescence was quenched using TrueBlack®
Lipofuscin Autoﬂuorescence Quencher. Tissue was surrounded with a hydrophobic
barrier using a barrier pen and incubated with TUNEL reaction mixture for 1 h
at 37 °C in a humidiﬁed atmosphere in the dark. Sections were double stained with
Hoechst 33342 (Molecular Probe, H3570, at 50 µg/ml for 10 min at room
temperature) to visualize all the nuclei in the ﬁeld. The sections were observed
under a Zeiss Videomicroscope (Axiovert200M). Percentage of cell death was
determined on stitched image of the whole kidney section.
A total of 1500 cells were seeded in a 48-well plate with and without
1 µg/ml DOX. The next day, cells were treated either with vehicle (DMSO) or
TM (1 µg/ml). After 16 h, cells were ﬁxed with 4% w/v PFA in PBS (1 h) and
permeabilized (2 min on ice) with 0.1% TritonX-100 in 0.1% sodium citrate. Cells
were then incubated with TUNEL reaction mixture for 1 h at 37 °C in a humidiﬁed
atmosphere in the dark. Cells were washed twice in PBS and incubated with
Hoescht for 10 min at RT. Samples were analyzed on a Zeiss microscope with a ×20
objective (Axioplan2 Imaging) using an excitation wavelength at 488 nm. Images
were processed and quantiﬁed.
Histology. Kidneys were dissected, decapsulated and ﬁxed in 4% paraformalde-
hyde in DPBS (Dulbecco’s Phosphate Buffered Saline; Gibco BRL Life Technolo-
gies) for 24 h. Fixed tissues were dehydrated in graded ethanol and xylene and
embedded in parafﬁn. Sequential sections of 5 μm were mounted onto Superfrost-
plus glass slides. After deparafﬁnization, sections were stained with hematoxylin
and eosin. Tubular lesions were quantiﬁed using the Image J software.
Chemicals. All chemicals were obtained from Sigma-Aldrich, except for Fura-2,
AM from Molecular Probes (Invitrogen, France). Culture mediums were purchased
from Invitrogen, France. FBS was purchased from Thermo Scientiﬁc HyClone.
Metabolic parameters. Procedures to measure metabolic parameters in mice
were previously described63.
Electrophysiological measurements of ER-enriched liposomes. ER microsomes
from PCTs enriched with PC2 and eGFP or PC2 and TMEM33 were fused to lipid
bilayers7,10. Experiments were performed with 250 mM HEPES-Tris solution,
pH 7.35 on the cis and 250 mM HEPES, 55 mM Ba(OH)2 solution, pH 7.35 on
the trans side. Divalent cation concentrations on the cytoplasmic side of the
PC2 channel were maintained by adjusting the ratio of calcium and EGTA. PC2
channels were activated by increasing calcium on the cis side. Channel activity was
recorded for 2 min at each calcium concentration under voltage-clamp conditions
on a Bilayer Clamp BC-525C (Warner Instuments, Hartford, CT, USA), ﬁltered
at 1 kHz and digitized at 5 kHz. Data was acquired and analyzed with pClamp9
(Axon Instruments, Burlingame, CA).
Zebraﬁsh experiments. Zebraﬁsh strains: zebraﬁsh were maintained according to
institutional and national ethical and animal welfare guidelines. All experiments
were performed under UK Home Ofﬁce licenses 40/3708 and 70/8588. The
zebraﬁsh lines Tg(-26wt1b:EGFP)li1 64 and tmem33sh44343 were used.
Zebraﬁsh morpholino injections: Embryos were injected at the 1 cell stage. A
morpholino complementary to the ATG region of zebraﬁsh pkd2 was injected at
1 ng (5’-AGGACGAACGCGACTGGAGCTCATC-3’)42. A concentration of 0.4 ng
or 1 ng control morpholino (5’- CCTCTTACCTCAGTTACAATTTATA-3’) was
injected in these experiments.
Image acquisition and analysis: Zebraﬁsh embryos were imaged at 52–55hpf
when cysts became visible, using a Leica M165FC stereo microscope and images
were acquired using Leica LASX software. Images were quantiﬁed using FIJI v1.52i.
Zebraﬁsh renal phenotype analysis was double blinded.
Statistical analysis. When appropriate, signiﬁcance of the differences was tested
with a permutation test (R Development Core Team: http://www.r-project.org/)
(n < 30) or with two samples t test (n > 30). One star indicates p < 0.05, two stars
p < 0.01 and three stars p < 0.001. Data represent mean ± standard error of the
mean. The number of independent times each experiment has been repeated (n) is
indicated throughout the manuscript and is shown in ﬁgures or indicated in the
text. The number of mice (N) used is also indicated throughout the ﬁgures.
Ethical issues. Experiments were carried out in accordance with the guidelines of
the national institutional ethical committee for experimental animals and conform
to the European community standards for the care and use of laboratory animals.
All manipulations involving animals were carried out under controlled laboratory
conditions by qualiﬁed personnel. The procedure followed for mouse euthanasia
was in strict accordance with the European community standards on the care
and use of laboratory animals. Animals were obtained from government-approved
animal-raising companies, and a register was kept to record the origin of each
animal, all its movements within the laboratory, and the reason for death.
This study was approved by our local Committee for ethical and safety issues
(CIEPAL-Azur).
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Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Raw data for Figs. 1a, b; 2; 3a, b; 3d; 4a–g; 5a–f; 6; 7; 8; Supplementary Figs. 1a, b, d-f; 2,e,
2f, 2h, 2j; 3,a-d; 4,d-f; 5, b; 6a-f; 9,a, b, e, f and 10 are provided as a Source Data ﬁle. All
data are available from the corresponding author upon reasonable request.
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